Profile data is unavailable for this security.
About the company
Nephro Care India Limited is an India-based healthcare provider that specializes in the treatment of kidney-related diseases. The Company’s main business is to provide a comprehensive 360-degree healthcare service to patients with kidney-related services. The Company offers a range of clinical and lifestyle solutions and services and renal insufficiency treatment to patients. The treatment framework covers the entire range of lifestyle, physiological and spiritual aspects of wellness. The Company offers various services at its clinics, including Inhouse Dialysis Unit; Outpatient Services in areas of Nephrology, Diabetology, Cardiology, Ophthalmology and Neurology; NABL accredited inhouse Pathology; Inhouse Pharmacy; Advanced diagnostic facilities; Renal Nutrition department; Home Care; Mukti (Lifestyle Support Program), and Home Dialysis. It also offers other services, such as Pulmonary function test, EMG/NCV-testing, Uroflowmetry-a test, Polysomnography and others.
- Revenue in INR (TTM)--
- Net income in INR--
- Incorporated2014
- Employees--
- LocationNephro Care India LtdKOLKATA 700098IndiaIND
- Phone+91 8 069841500
- Websitehttps://www.nephrocareindia.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lotus Eye Hospital and Institute Ltd | 482.10m | 29.15m | 1.44bn | 336.00 | 49.08 | 2.43 | 21.69 | 2.99 | 1.41 | 1.41 | 23.32 | 28.57 | 0.7428 | 5.90 | 39.68 | 1,434,821.00 | 4.49 | 4.15 | 4.92 | 4.58 | 52.43 | 53.24 | 6.05 | 6.09 | 1.45 | 28.75 | 0.0184 | -- | 2.48 | 4.64 | -28.52 | 32.71 | 3.79 | -- |
| Unihealth Consultancy Ltd | -100.00bn | -100.00bn | 1.86bn | 510.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 19.29 | -- | 101.04 | -- | -- | -- |
| QMS Medical Allied Services Ltd | -100.00bn | -100.00bn | 2.08bn | 51.00 | -- | 2.79 | -- | -- | -- | -- | -- | 41.75 | -- | -- | -- | -- | -- | 14.62 | -- | 36.19 | -- | 21.53 | -- | 7.52 | 1.33 | -- | 0.3078 | 0.00 | -28.90 | 315.81 | -40.42 | 296.61 | -- | -- |
| Nephro Care India Ltd | -100.00bn | -100.00bn | 5.15bn | -- | -- | 37.00 | -- | -- | -- | -- | -- | 8.45 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.8197 | -- | 0.00 | -- | 399.14 | -- | 19,920.41 | -- | -- | -- |
| Max India Ltd | 1.76bn | -563.80m | 13.75bn | 19.00 | -- | 2.79 | -- | 7.83 | -13.08 | -13.08 | 40.74 | 114.05 | 0.2443 | 2.03 | 30.12 | -- | -7.87 | -- | -9.95 | -- | 66.91 | 65.15 | -32.22 | -24.36 | 2.43 | -18.42 | 0.0813 | -- | -12.64 | 2.82 | -443.01 | -- | -- | -- |
| GPT Healthcare Ltd | 3.04bn | 377.89m | 14.22bn | 1.89k | 36.70 | 6.51 | 25.50 | 4.68 | 4.72 | 4.72 | 38.00 | 26.63 | 0.9044 | 7.36 | 12.37 | 1,610,983.00 | 11.24 | 10.18 | 14.73 | 12.97 | 79.32 | 77.99 | 12.43 | 10.33 | 0.9326 | 10.81 | 0.1227 | 0.00 | 10.85 | 18.42 | 22.46 | 26.15 | -5.19 | -- |
| Krsnaa Diagnostics Ltd | 6.20bn | 568.40m | 22.48bn | 2.56k | 39.96 | 2.78 | 17.11 | 3.63 | 17.42 | 17.42 | 190.03 | 250.79 | 0.5953 | 4.38 | 4.82 | -- | 5.46 | 6.72 | 6.68 | 8.59 | 77.24 | 82.55 | 9.17 | 11.74 | 1.37 | 4.23 | 0.1648 | -- | 27.20 | 24.25 | -8.49 | -- | 14.21 | -- |
